À propos
Dr Anna Kirby is a Consultant Clinical Oncologist specialising in the treatment of patients with breast cancer. She leads research into novel breast radiotherapy techniques at the Royal Marsden and Institute of Cancer Research. She is Chief Investigator of the UK HeartSpare study, and breast lead investigator on the CORE trial evaluating the role of stereotactic radiotherapy in treating metastatic disease.
Dr Kirby graduated from Cambridge University in 1995 with a first-class honours degree in Medicine and Psychology. Her specialist oncology training was completed at The Royal Marsden and Guy's and St Thomas' Hospitals following which she undertook a research degree at the Institute of Cancer Research. Her publications describe methods for improving the accuracy of breast cancer radiotherapy and for reducing late side-effects of treatment including heart disease. Her work in heart-sparing breast radiotherapy has changed national practice. Her current research interests include combining breath-hold and volumetric-modulated arc therapy to minimise heart and lung doses in women with lymph-node positive breast cancer, reversing the order of breast cancer treatments to reduce the impact of radiotherapy on breast reconstructions, and investigating the applications of MR-linac technology to the treatment of breast cancer.
She is also a keen singer, cook and tennis player.
Diseases, Medical Tests and TreatmentsHeart-Sparing Breast Radiotherapy
Stereotactic Radiotherapy
Breast Radiotherapy
Dr Kirby graduated from Cambridge University in 1995 with a first-class honours degree in Medicine and Psychology. Her specialist oncology training was completed at The Royal Marsden and Guy's and St Thomas' Hospitals following which she undertook a research degree at the Institute of Cancer Research. Her publications describe methods for improving the accuracy of breast cancer radiotherapy and for reducing late side-effects of treatment including heart disease. Her work in heart-sparing breast radiotherapy has changed national practice. Her current research interests include combining breath-hold and volumetric-modulated arc therapy to minimise heart and lung doses in women with lymph-node positive breast cancer, reversing the order of breast cancer treatments to reduce the impact of radiotherapy on breast reconstructions, and investigating the applications of MR-linac technology to the treatment of breast cancer.
She is also a keen singer, cook and tennis player.
Diseases, Medical Tests and TreatmentsHeart-Sparing Breast Radiotherapy
Stereotactic Radiotherapy
Breast Radiotherapy
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Anna Kirby
Formation et études
-
2002–2008 MD · Medicine and Surgery
-
2008–2012 Residency · Oncologie
-
2012–2013 Fellowship · Subspecialty training
Carrière et postes
-
2012-09–2013-08 Junior consultant
Licences et assurance
Licences médicales
GB — Organización Médica Colegial de España (OMC)
Certifications du conseil
European Board of Oncologie
Assurance responsabilité professionnelle :
HDI Global · 2,000,000 EUR couverture · No claims on file
Procédures réalisées
| Procédure | Code | Total à vie |
|---|---|---|
| GP consultation | 99213 | 1,074 |
| Annual physical exam | 99395 | 2,156 |
| Vaccination administration | 90471 | 1,204 |
| Minor procedure (skin) | 17110 | 59 |
Services et tarifs
| Service | Durée | Modalité | Prix |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 90 min | in_clinic | 630.00 EUR |
| Minor procedure (skin) | 60 min | in_clinic | 720.00 EUR |
Cabinet, équipe & en pratique
Vidéos
Recherche et publications
indice h : 7 · i10 : 9
-
Outcomes of Oncologie in adults — a multi-centre cohort
DOI: 10.3196/euroclin.2025.0 · PMID: 32939095 · cité par 50
-
European registry analysis of Oncologie outcomes
DOI: 10.2347/euroclin.2024.1 · PMID: 38670949 · cité par 104
Conférences invitées
- Practical updates in Oncologie European Annual Congress (Oncologie) · Vienna · 2024 · invited
- Single-centre experience in Oncologie National Society Meeting · London · 2023 · oral abstract
Récompenses et adhésions
Récompenses
- 🏆 Top-rated Oncologie — London · EuroClinics Patient Choice · 2025 · regional
Adhésions à des sociétés
- WONCA Europe — Family Doctors — Member · Depuis 2013
- national college of family doctors — Member · Depuis 2013
- European Union of Medical Specialists (UEMS) — Member · Depuis 2013
Articles de ce médecin
- Patient education Patient guide to Oncologie
- Awareness When should you see a oncologie?
Pour les patients internationaux
- Coordinateur
- Patient liaison · dr.anna.kirby@euroclinics.example
Emplacement
1 baliseAvis des patients
Partagez votre expérience — aidez d'autres patients à trouver le bon médecin. Rédiger un avis →
Avis récents
-
★★★★★ ✓ Vérifié Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Vérifié Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Vérifié Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.